| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.60▲ | 2.60▲ | 2.60▲ | 2.63▲ | 3.19▼ |
| MA10 | 2.63▲ | 2.64▲ | 2.65▲ | 2.67▲ | 4.00▼ |
| MA20 | 2.67▲ | 2.68▲ | 2.69▼ | 3.16▼ | 8.59▼ |
| MA50 | 2.72▼ | 2.84▼ | 3.18▼ | 4.55▼ | 28.10▼ |
| MA100 | 3.30▼ | 3.65▼ | 3.57▼ | 9.42▼ | N/A |
| MA200 | 3.84▼ | 3.83▼ | 6.22▼ | 18.84▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.023▲ | 0.033▲ | 0.098▲ | 2.213▲ |
| RSI | 50.263▲ | 47.435▼ | 45.502▼ | 34.463▼ | 23.231▼ |
| STOCH | 21.473 | 21.473 | 25.009 | 40.906 | 13.051▼ |
| WILL %R | -42.857 | -42.857 | -45.455 | -61.290 | -96.511▼ |
| CCI | 52.555 | 51.865 | 21.412 | -30.329 | -83.730 |
|
Monday, June 29, 2026 03:00 PM
Silexion Therapeutics (SLXN) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-21.20 and quarterly revenue of N/A. In the most recent quarter (Q1), Silexion ...
|
|
Saturday, May 30, 2026 12:40 AM
Detailed price information for Silexion Therapeutics Corp (SLXN-Q) from The Globe and Mail including charting and trades.
|
|
Wednesday, May 20, 2026 05:30 AM
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/07/26 | 2.66 | 2.695 | 2.66 | 2.69 | 20,205 |
| 01/07/26 | 2.56 | 2.68 | 2.55 | 2.585 | 23,838 |
| 30/06/26 | 2.53 | 2.63 | 2.50 | 2.55 | 49,156 |
| 29/06/26 | 2.6901 | 2.775 | 2.5401 | 2.57 | 43,597 |
| 26/06/26 | 2.662 | 2.89 | 2.662 | 2.75 | 31,619 |
| 25/06/26 | 2.65 | 2.80 | 2.60 | 2.73 | 27,575 |
| 24/06/26 | 2.65 | 2.85 | 2.5293 | 2.70 | 91,906 |
| 23/06/26 | 2.5739 | 2.8899 | 2.40 | 2.71 | 379,999 |
| 22/06/26 | 2.745 | 2.79 | 2.63 | 2.70 | 52,013 |
| 18/06/26 | 2.75 | 2.9099 | 2.65 | 2.73 | 67,811 |
|
|
||||
|
|
||||
|
|